Head to head
Uranium Royalty vs Cameco
Side-by-side on the measures that matter, with a plain-English read. Full detail: UROY · CCJ
UROY
Uranium Royalty
4.19-1.18%
1-year price shape — -0% over the period
Quant Rating C · 36/100
vs
CCJ
Cameco
89.07-4.25%
1-year price shape — +3% over the period
Quant Rating D · 45/100
1-year performance, rebased to 100
Uranium Royalty edges it on the scoreable measures. Uranium Royalty trades cheapest on trailing earnings.
| UROY | CCJ | |
|---|---|---|
| Snapshot | ||
| Sector | Uranium | Uranium |
| Last price | 4.19 | 89.07 |
| Change today | -1.18% | -4.25% |
| 1-year return | -0.5% | +3.2% |
| Market cap | $1.60B | $38.79B |
| 52-week range | 2.56 – 5.52 | 77.54 – 135.24 |
| Valuation | ||
| P/E (TTM) | 11.03 | 156.81 |
| P/E percentile, own 5-yr range | 53rd | 72nd |
| P/B | 1.68 | 7.75 |
| Dividend yield | 0.00% | 0.19% |
| Profitability & growth | ||
| EPS (TTM) | 0.29 | 0.95 |
| Net profit (TTM) | $110.51M | $412.45M |
| Revenue (TTM) | $214.26M | $3.47B |
| Revenue growth (YoY) | +112.9% | -7.2% |
| Gross margin | 33.1% | 26.9% |
| Operating margin | 30.2% | 14.8% |
| Net margin | 25.9% | 10.2% |
| Free cash flow (TTM) | $208.01M | $555.92M |
| Ownership & sentiment | ||
| Institutional ownership | 12.6% | 65.9% |
| Insider activity (12mo) | 1 buy / 0 sell | 0 buy / 33 sell |
| Short interest (% of float) | 1.4% | 2.0% |
| Analyst consensus | 100% buy (1) | 89% buy / 11% hold (9) |
| Analyst price target | $5 (+7%) | $125 (+41%) |
| StockVane view | ||
| StockVane Quant Rating | C (36) | D (45) |
| Company | ||
| Employees | 14 | 3,082 |
| Founded | 2017 | 1988 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.